• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Herpes Simplex Amplicon Vectors

        互联网

        669
        The key fundamental problem for effective gene therapy remains gene delivery. Gene therapy has achieved some modest success in animal and human experiments (1 7 ). However, effective gene delivery remains the chief obstacle. Herpes simplex virus type 1 (HSV-1) vectors offer several improvements over other established viral vectors including a larger DNA carrying capacity, wide tropism, high-transduction efficiency, and the potential to establish latency. HSV-1 vectors can efficiently transfer genes in vivo (1 ,8 11 ) to a variety of cell types including muscle, neural, and tumor cells (8 ,10 ,12 17 ). Two basic designs of HSV vectors, replication defective and amplicon, are under development (3 ,12 ,18 22 ). Plasmids with an HSV-1 lytic replication origins (ori S) and terminal packaging signal sequences, can be amplified and packaged into infectious HSV-1 virions in the presence of transacting helper virus (12 ,18 19 ,23 ). This plasmid system permits easier cloning and carries genomic information between prokaryotic and eukaryotic cells as a shuttle vector (19 ). The amplicon systems retain the merits of HSV-1 vectors including high efficiency of gene transfer in vitro and in vivo, wide range of host and neurotropism, but viral stocks tend to have lower titers and production is time consuming (18 ,24 28 ). Furthermore, amplicon systems can package large DNA fragments (>15 kb) efficiently. These properties make HSV amplicon vectors useful tools for a number of applications especially cancer therapy.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序